Respiratory potentially pathogenic bacteria are associated with increased disease severity in neonates with respiratory syncytial virus infection Authors: Xiaofeng Yang, Lei Ding, Xin Ding Published: 2025 ABSTRACT AbstractBackgroundRespiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in infants under two years of age. However, the presence of respiratory bacterial pathogens and their impact on RSV severity in neonates remains inadequately understood. We therefore investigated the profiles of respiratory potentially pathogenic bacteria (PPB) in neonates with RSV and assessed their association with disease severity.MethodsWe conducted a retrospective cohort study at the Children’s Hospital of Soochow University, including neonates diagnosed with LRTIs from July 2017 to June 2024. RSV-positive cases were categorized by disease severity based on the need for oxygen support, mechanical ventilation, or NICU admission. The distribution of PPB and their clinical implications were analyzed.ResultsAmong 4,091 neonates with LRTI, 542 were RSV-positive (419 non-severe, 123 severe). In RSV-positive neonates, the presence of PPB was associated with a higher incidence of high fever (P = 0.002), feeding difficulty (P = 0.019), cardiovascular complications (P = 0.048), and oxygen supplementation (P = 0.015), as well as prolonged oxygen therapy (P = 0.018) and increased NICU admission rates (P = 0.028). Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae were the most commonly detected PPB. Notably, both overall PPB presence and K. pneumoniae detection were independently associated with severe RSV infection in neonates (P = 0.013 and 0.041, respectively).ConclusionPPB, particularly K. pneumoniae, play a significant role in exacerbating the severity of RSV infection in neonates. These findings highlight the necessity of considering bacterial pathogens in the clinical management of RSV infection in neonates.Keywords: Respiratory syncytial virus, Neonate, Potentially pathogenic bacteria, Klebsiella pneumoniae, Severity Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in young children, particularly those under two years of age [1]. Annually, RSV causes approximately 33 million episodes of LRTI in children younger than five years, resulting in 3.6 million hospitalizations and 118,200 deaths globally [2]. Although RSV typically follows a seasonal pattern, this can vary across years and geographical regions [3]. It remains unclear why some children infected with RSV develop severe disease, while others experience only mild symptoms. Severe manifestations, including bronchiolitis and pneumonia, are more common in vulnerable populations such as neonates, premature infants, and immunocompromised individuals [4–6]. Disease severity is often linked to an abnormal immune response, involving inflammatory cytokines such as CXCL8 and IL-6 [5, 7]. Recent clinical evidence suggests that the respiratory microbiome may influence both the severity of RSV and the risk of associated complications. For instance, Brealey et al. found that Streptococcus pneumoniae detection correlated with severe RSV disease in infants younger than two years [8]. Similarly, Lin et al. reported an association between Haemophilus bacteria and more severe RSV infections [9]. However, data on respiratory potentially pathogenic bacteria (PPB) in neonatal RSV infections remain limited. This study aims to characterize the PPB profiles in neonates with RSV and evaluate their potential impact on clinical outcomes. Methods and materials Study design and participants We enrolled neonates (≤ 28 days old) admitted with LRTI (either bronchiolitis or pneumonia) at the Neonatal Department of the Children’s Hospital of Soochow University, China, from July 2017 to June 2024. This hospital is the only tertiary pediatric center in Suzhou, southeast China, and serves the majority of the local pediatric population. Neonates with RSV infection were classified as severe or non-severe based on clinical outcomes. Severe RSV was defined by the requirement for (1) supplemental oxygen, (2) non-invasive or invasive mechanical ventilation, or (3) intensive care unit (NICU) admission. Non-severe cases included all other RSV-infected neonates who did not meet these criteria. Clinical sample collection and laboratory testing Sputum samples were collected from all neonates with LRTI within 24 h of admission. A suction catheter was gently inserted into the lower part of the pharynx, with a penetration depth set at 7–9 cm for the nasopharyngeal aspirate collection. Total nucleic acids were extracted from the collected specimens for RSV and microbial DNA testing. RSV was identified using nucleic acid extracts, employing assays developed by Health Gene Technologies (Ningbo, China). The primers, probes and amplification conditions were available upon request. All steps of the nucleic acid extraction and PCR test were carried out in parallel with positive and negative controls. Sputum samples were also tested for respiratory microbial DNA using the VITEK MS system based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Freshly cultured microbial colonies were applied to a target plate, and mass spectrometry was performed after substrate application. Quality control was ensured by using Escherichia coli (E. coli) ATCC 8739. Definitions and clinical criteria Low birthweight was defined as birthweight < 2500 g; preterm birth as < 37 weeks’ gestation; and small for gestational age (SGA) as birth weight (BW) below the 10th percentile for gestational age (GA) and sex. An abnormal C-reactive protein (CRP) level was defined as a concentration exceeding 10 mg/L [10]. Underlying medical conditions were defined as the presence of one or more of the following: (1) chromosomal abnormalities, (2) confirmed genetic disorders, (3) autoimmune diseases, (4) congenital heart disease requiring intervention, (5) chronic lung disease (including bronchopulmonary dysplasia), or (6) severe anemia (defined as hemoglobin < 7 g/dL in stable neonates or < 10 g/dL in critically ill neonates). In cases where multiple types of oxygen support were used, only the highest level was counted (i.e., invasive mechanical ventilation (IMV) > non-invasive mechanical ventilation > other forms of oxygen support). Statistical analysis Continuous variables were presented as medians with interquartile ranges (IQR), and categorical variables as counts and proportions. The Mann-Whitney test was used for nonparametric data comparisons, while the Chi-square (χ2) test or Fisher’s exact test was used for categorical data. Multivariable logistic regression analyses assessed independent predictors of severe RSV. Odds ratios (ORs) were assessed with 95% confidence intervals (CIs). Statistical analysis was performed using SPSS software (version 22.0, IBM Corp., Armonk, NY, USA), with a significance level set at P < 0.05. Ethic approval This study was approved by the Medial Ethics Committees of the Children’s Hospital of Soochow University (2013002). Results Characteristics of the study population A total of 4,091 neonates with LRTIs were enrolled, among whom 542 were positive for RSV by PCR. Of these RSV-positive neonates, 33.9% (184/542) had detectable respiratory PPB, compared to 25.7% (911/3,543) among RSV-negative cases (P < 0.001). The RSV-positive cases were further classified into 419 non-severe and 123 severe cases (Fig. 1). Baseline characteristics of neonates with RSV infection are presented in Table 1. There were no significant differences between the non-severe and severe groups in terms of sex, age of onset, gestational age, birth weight, low birth weight, or SGA status. However, the severe group demonstrated a significantly higher proportion of preterm births, underlying conditions, and PPB detection (P < 0.05). The flowchart of the number of cases included in the study. LRTIs, lower respiratory tract infections; RSV, respiratory syncytial virus Table 1Comparison of baseline characteristics between neonates with non-severe and severe RSV infectionRSV (n = 542)Non-severe RSV (n = 419)Severe RSV (n = 123)P valueMale, n (%)274 (50.6)203 (48.4)71 (57.7)0.070Age of onset (days), median (IQR)20.0 (15.0, 24.0)20.0 (15.0, 24.0)20.0 (15.0, 25.0)0.499Gestational age(weeks), median (IQR)39.0 (38.4, 40.0)39.0 (38.4, 40.0)39.0 (38.0, 40.0)0.079Birthweight (g), median (IQR)3375.0 (3100.0, 3650.0)3380.0 (3100.0, 3610.0)3360.0 (3000.0, 3670.0)0.797Low birthweight, n (%)9 (1.7)5 (1.2)4 (3.3)0.124Preterm birth, n (%)22 (4.1)10 (2.4)12 (9.8)< 0.001SGA, n (%)25 (4.6)21 (5.0)4 (3.3)0.624Underlying conditions, n (%)12 (2.2)4 (1.0)8 (6.5)0.001PPB detected, n (%)184 (33.9)131 (31.3)53 (43.1)0.015Median (IQR) for non-normally distributed variables; RSV, respiratory syncytial virus; IQR, interquartile ranges; SD, standard deviation; SGA, small for gestational age; PPB, potentially pathogenic bacteria Comparison of baseline characteristics between neonates with non-severe and severe RSV infection Median (IQR) for non-normally distributed variables; RSV, respiratory syncytial virus; IQR, interquartile ranges; SD, standard deviation; SGA, small for gestational age; PPB, potentially pathogenic bacteria Characteristics of RSV infection in neonates with and without PPB co-detection Table 2 depicts the clinical features and outcomes of neonates with RSV infection, categorized by the presence or absence of PPB in respiratory samples. Indicators of disease severity were significantly higher in neonates with both RSV and bacterial pathogens. These neonates showed higher rates of high fever (P = 0.002), feeding difficulty (P = 0.019), cardiovascular complications (P = 0.048), and required oxygen therapy more frequently (P = 0.015). Their white blood cell (WBC) counts were also significantly elevated (P = 0.001). Moreover, this group required a significantly longer duration of oxygen therapy (P = 0.018) and was more frequently admitted to the NICU (P = 0.028). Table 2Clinical features and outcomes of RSV-positive neonates with or without PPBRSV alone (n = 358)RSV with PPB detected (n = 184)P valueMale sex, n (%)170 (47.5)98 (53.3)0.203Age of onset (days), median (IQR)20.0 (15.0, 24.0)20.0 (15.0, 24.0)0.515Gestational age(weeks), median (IQR)39.1 (38.4, 40.1)39.0 (38.3, 40.0)0.184Birthweight (g), median (IQR)3350 (3100, 3603)3410 (3073, 3650)0.506Low birthweight, n (%)5 (1.4)4 (2.2)0.497Preterm birth, n (%)16 (4.5)6 (3.3)0.500SGA, n (%)15 (4.2)10 (5.4)0.513Underlying conditions, n (%)5 (1.4)7 (3.8)0.071Fever (≥ 37.5 °C), n (%)160 (44.7)95 (51.6)0.125High fever (≥ 39 °C), n (%)3 (0.8)13 (2.4)0.002Cough, n (%)355 (99.2)183 (99.5)0.704Wheezing, n (%)83 (23.2)52 (28.3)0.196Cyanosis, n (%)38 (10.6)29 (15.8)0.085Tachypnea, n (%)141 (39.4)89 (47.3)0.078Tachycardia, n (%)19 (5.3)17(9.2)0.082Feeding difficulty, n(%)48 (13.4)39 (21.2)0.019Seizures, n (%)2 (0.6)1 (0.5)1.000Diarrhea or vomiting, n (%)92 (25.7)58 (31.5)0.151Any complication, n (%)8 (2.2)8 (4.3)0.169Cardiovascular complications, n (%)1 (0.3)4 (2.2)0.048Respiratory diseases, n (%)4 (1.1)5 (2.7)0.176WBC count (×109/L), median (IQR)8.2 (7.0, 10.2)9.2 (7.2, 11.7)0.001Abnormal CRP level, n (%)16 (4.5)15 (8.2)0.080ALT (U/L), median (IQR)18.0 (13.1, 23.1)19.0 (12.7, 26.1)0.335Any form of oxygen supplementation, n (%)70 (19.6)53 (28.8)0.015Duration of oxygen administration (days), median (IQR)0 (0, 0)0 (0, 2.8)0.018Non-invasive ventilation, n (%)6 (1.7)7 (3.8)0.125Mechanical ventilation, n (%)1 (0.3)3 (1.6)0.116NICU admission, n (%)7 (2.0)10 (5.4)0.028Death, n (%)0 (0)1 (0.5)0.330PPB, potentially pathogenic bacteria; IQR, interquartile ranges; SD, standard deviation; SGA, small for gestational age; WBC, white blood cell; CRP, C-reactive protein; ALT, alanine aminotransferase; RSV, respiratory syncytial virus; NICU, neonatal intensive care unit Clinical features and outcomes of RSV-positive neonates with or without PPB PPB, potentially pathogenic bacteria; IQR, interquartile ranges; SD, standard deviation; SGA, small for gestational age; WBC, white blood cell; CRP, C-reactive protein; ALT, alanine aminotransferase; RSV, respiratory syncytial virus; NICU, neonatal intensive care unit There was one reported death among the RSV-positive infants. A 26-day-old male, diagnosed with patent ductus arteriosus, atrial septal defect, and pulmonary hypertension, developed pulmonary hemorrhage, respiratory failure, and heart failure. Sputum cultures revealed Staphylococcus aureus (S. aureus) and Klebsiella pneumoniae (K. pneumoniae). The infant ultimately died of multiple organ failure. Detection of PPB in RSV-positive neonates Table 3 shows PPB detection among RSV-positive neonates. Of the 542 infants, 184 (33.9%) tested positive for PPB. The most frequently identified pathogens were S. aureus (17.2%, 93/542), Escherichia coli (6.1%, 33/542), and K. pneumoniae (3.5%, 19/542). A comparison between severe and non-severe RSV cases revealed a significantly higher rate of bacterial detection in the severe group (43.1% vs. 31.3%, P = 0.015). Notably, K. pneumoniae was more frequently identified in severe RSV cases than in non-severe cases (7.3% vs. 3.5%, P = 0.009) (Table 3). Table 3PPB and RSV disease severityAll RSV (n = 542)Non-severe RSV (n = 419)Severe RSV (n = 123)P valueTotal bacterial positive cases, n (%)184 (33.9)131(31.3)53 (43.1)0.015S. aureus, n (%)93 (17.2)71 (16.9)22 (17.9)0.808E. coli, n (%)33 (6.1)26 (6.2)7 (5.7)0.834K. pneumoniae, n (%)19 (3.5)10 (2.4)9 (7.3)0.009M. catarrhalis, n (%)12 (2.2)8 (1.9)4 (3.3)0.483H. influenzae, n (%)11 (2.0)8 (1.9)3 (2.4)0.719S. pneumoniae, n (%)8 (1.5)5 (1.2)3 (2.4)0.390P. aeruginosa, n (%)3 (0.6)2 (0.5)1 (0.8)0.539A. baumannii, n (%)3 (0.6)1 (0.2)2 (1.6)0.131PPB, potentially pathogenic bacteria; RSV, respiratory syncytial virus PPB and RSV disease severity PPB, potentially pathogenic bacteria; RSV, respiratory syncytial virus Impact of bacterial pathogens on RSV disease severity Given that age, male sex, prematurity, low birthweight and underlying conditions are established risk factors for severe RSV and may act as confounders, two logistic regression analyses were conducted. The first model assessed the association between PPB and severe RSV after controlling for these covariates (Fig. 2A). The second analysis evaluated the role of K. pneumoniae detection in severe RSV (Fig. 2B). Detection of PPB was independently associated with an increased risk of severe RSV (P = 0.013) (Fig. 2A). Neonates with K. pneumoniae had 2.781 times greater odds of developing severe RSV compared to those without this pathogen (P = 0.041) (Fig. 2B). Multivariate analysis of risk factors associated with severe RSV. Small for gestational age (SGA) was defined as birth weight below the 10th percentile for gestational age and gender. GA, gestational age; BW, birthweight; CI, confidence interval; PPB, potentially pathogenic bacteria Discussion The aim of this study was to evaluate the impact of respiratory PPB on the clinical presentation and outcomes of RSV infection in neonates in Suzhou, southeast China. Our findings indicate that the presence of PPB significantly exacerbates both the symptoms and prognosis of RSV-positive neonates. Specifically, neonates with RSV and PPB co-detection experienced more severe symptoms compared to those with RSV alone. These neonates had a higher frequency of high fever, feeding difficulties, cardiovascular issues, oxygen requirements, NICU admission, a longer duration of oxygen therapy, and elevated WBC counts. An increasing body of evidence suggests a link between PPB and increased severity of RSV infection [5, 8, 11]. Zhong et al. found that neonates with both RSV and PPB were significantly more likely to exhibit worse clinical symptoms, including recurrent wheezing, elevated CRP levels, and more pronounced chest X-ray abnormalities [12]. Other studies have also shown that co-detection of bacterial pathogens in RSV patients increases the risk of developing severe pneumonia and the need for mechanical ventilation or tracheal intubation [13]. A retrospective cohort study conducted at National Taiwan University Hospital over a 10-year period found that children with RSV and bacterial co-infection were more likely to require ICU care, had higher CRP levels, and more frequently presented with hyponatremia [14]. The prevalence and distribution of co-detected bacteria in hospitalized children with RSV varies across different studies [14–16]. In our cohort, 33.9% of neonates with RSV tested positive for bacterial pathogens, with S. aureus (17.2%), E. coli (6.1%), and K. pneumoniae (3.5%) being the most frequently detected bacteria. These results partially align with findings from Taiwan [17] and the United States [18], where S. aureus was likewise the most commonly detected bacterium in RSV-infected patients. However, other reports show notable differences. For example, Piters et al. in the U.S. found that Haemophilus influenzae, Streptococcus, Corynebacterium, Moraxella, and S. aureus were the most prevalent bacteria in children under two years old with RSV infection [19]. In Chongqing, China, Li et al. observed that the top five co-detected bacteria in children with RSV-induced pneumonia were S. pneumoniae, H. influenzae, E. coli, M. catarrhalis, and S. aureus [13]. These observed discrepancies likely result from several contributing factors, including geographic variations in bacterial epidemiology, differences in patient demographics (particularly age distribution), and variations in bacterial detection methods and sampling techniques. It is well acknowledged that pediatric patients with a history of prematurity, low birthweight or underlying diseases such as hemodynamically significant congenital heart disease are at increased risk for severe RSV disease [20–22]. Male infants also show a higher likelihood of RSV-related hospitalization [23]. In our study, we performed logistic regression analyses incorporating these potential confounders along with PPB detection, and found that PPB detection was significantly associated with an increased risk of severe disease. During RSV infection, pathogenic bacteria can adhere to RSV-infected epithelial cells in the nasopharynx, disrupt natural barriers, and facilitate translocation of opportunistic bacteria into the bloodstream. This process increases bacterial load [24] and impairs viral clearance [25, 26], contributing to pneumonia and recurrent wheezing. The host immune response also plays a crucial role in RSV disease severity. Respiratory pathogens are thought to influence this immune response by modulating the production and activity of cytokines, chemokines, and immune cells [27–29]. In our study, neonates with bacterial co-detection exhibited significantly higher rates of high fever and leukocytosis, further indicating immune activation. S. aureus was the most commonly detected bacterium in neonates with RSV. However, there was no significant difference in S. aureus prevalence between severe and non-severe RSV cases in our study. Much research on S. aureus and RSV has explored their synergistic interaction, which seems to be bidirectional. RSV infection can enhance S. aureus growth in the lungs by overactivation of neutrophils, leading to cell death and impaired neutrophil accumulation. Additionally, RSV impairs the bactericidal capacity of alveolar macrophages [30]. Some studies have found a strong association between RSV and S. aureus co-detection and severe symptoms [13, 14, 31], while other studies have reported the opposite. These studies found a reduced abundance of S. aureus in the respiratory microbiota and a negative correlation between its presence and disease severity in RSV-infected infants [19, 32]. We found that K. pneumoniae was more frequently detected in severe RSV cases than in non-severe cases. Notably, logistic regression analysis showed that its presence was independently associated with a significantly increased risk of severe disease. This aligns with findings from other Asian studies reporting that K. pneumoniae co-detection and elevated Klebsiella abundance increase the risk of recurrent wheezing both during RSV infection and later in life [12, 33]. Potential mechanisms involve Klebsiella-induced immune modulation. Recent investigations have demonstrated that increased Klebsiella abundance is associated with elevated levels of Th2-related cytokines (IL-13, IL-17A) and pro-inflammatory mediators, including TNF-α, IL-1β, IL-6, IL-8, and MCP-1 [34]. These immune alterations are well-recognized contributors to RSV pathogenesis and clinical deterioration, and may help explain the greater clinical severity observed in cases with Klebsiella co-detection. However, geographical variations in RSV-bacterial interactions are apparent. While our study highlights K. pneumoniae as a key contributor to disease severity, studies from Europe have more commonly implicated Haemophilus, Streptococcus, and Moraxella species [35]. Similarly, a U.S. study reported nasal H. influenzae colonization as a significant predictor of RSV severity [11]. These discrepancies likely reflect underlying differences in local bacterial ecology, host immune responses, and patterns of antimicrobial exposure. This study has several limitations. First, due to its retrospective design and single-center setting, data collection relied on the review of patient records, which may have resulted in missing information or misinterpretation of clinical evaluations. Second, the sample was limited to sputum cultures from neonates, which may have led to an underestimation of the role of PPB in RSV severity. Third, data collection coincided with periods of high COVID-19 transmission and altered RSV circulation, potentially affecting respiratory virus epidemiology through behavioral changes, shifts in healthcare-seeking behavior, or viral interference [28, 36]. Lastly, the immunization status of neonates against bacterial pathogens was unavailable, representing a potential confounding factor that warrants further investigation. In conclusion, neonates with co-detection of RSV and respiratory PPB experienced more severe clinical symptoms compared to those with RSV alone. The most commonly identified bacterial pathogens in neonates with RSV infection were S. aureus, E. coli, and K. pneumoniae. Notably, our study suggests that PPB, particularly K. pneumoniae, is an independent risk factor for severe RSV disease. These findings highlight the importance of considering bacterial co-detection in the clinical management of RSV infection in neonates. Acknowledgements Not applicable. Author contributions Xiaofeng Yang, Lei Ding and Xin Ding conceived and designed the study. Xiaofeng Yang and Lei Ding collected, analyzed and interpreted the data under the supervision of Xin Ding. Xiaofeng Yang drafted the manuscript. All authors reviewed and approved the final manuscript. Funding This work was supported by grants from National Natural Science Foundation of China (No. 81701490); and the Special Research Fund of Jiangsu Medical Association (SYH-32034-0112 (2024016)). Data availability The main data analyzed during this study are included in this article and further inquiries can be directed to the corresponding author. Declarations Ethics approval and consent to participate The study adhered to the Declaration of Helsinki’s ethical standards and received approval from the Medial Ethics Committees of the Children’s Hospital of Soochow University (2013002). Individual consent for this retrospective analysis was waived. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Xiaofeng Yang and Lei Ding contributed equally to this work. References Associated Data Data Availability Statement The main data analyzed during this study are included in this article and further inquiries can be directed to the corresponding author.